IBD & Intestinal Disorders
From the AGA Journals
IBD patients have limited protection against Omicron with third vaccine dose
Patients with IBD taking infliximab or tofacitinib may be more vulnerable to Omicron infection even after a third dose of a COVID-19 mRNA vaccine...
From the Journals
Vonoprazan triple therapy most cost-effective for H. pylori: Study
Rifabutin triple therapy (Talicia) is the second most cost-effective strategy for H. pylori eradication.
From the Journals
Dietary interventions can support IBD treatment
“The Internet has a dizzying array of diet variants touted to benefit inflammation and IBD, which has led to much confusion among patients, and...
From the Journals
Can nanotechnology help cure IBD?
“Due to the colonizing property of probiotics in colon tissues, the nanoparticles could be delivered to colon tissues by probiotics and released...
From the Journals
Upadacitinib curbed UC symptoms from Day 1 in study
“Clinicians treating IBD patients should take the time to response into consideration, because it leads to rapid improvement in quality of life...
From the Journals
Blame IBS on gravity intolerance?
The gravity hypothesis is provocative, “but the best thing about it is that it is testable.”
Latest News
Rosacea and the gut: Looking into SIBO
“There’s associative epidemiological evidence showing higher rates of SIBO among those with rosacea, and there are prospective studies” showing...
News from the FDA/CDC
FDA OKs first fecal microbiota therapy for recurrent C. difficile
From the Journals
Virtual yoga program appears to improve IBS symptoms, fatigue, stress
“With advances around the gut microbiome and the evolving science on the brain-gut axis, mind-body interventions could offer a therapeutic option...
From the Journals
Bloating common but often ignored: Survey
The findings suggest doctors should “proactively” ask about bloating, especially in adults at increased risk.